![]() |
|
|
Vol. 288, Issue 2, 550-560, February 1999
Department of Psychiatry, Uniformed Services University of
the Health Sciences, Bethesda, Maryland (J.R.G.); and
Laboratory of
Medicinal Chemistry, National Institute of Diabetes and Digestive and
Kidney Diseases, National Institutes of Health, Bethesda, Maryland
(J.R.G., F.H.E.W., K.C.R.)
Drugs that decrease drug-maintained responding at doses that do
not decrease other behaviors in animals may be suitable candidates for
development as medications to treat drug abuse in humans. The present
study examined whether this effect could be obtained with phentermine,
a drug that has been reported to decrease cocaine intake in humans.
Rhesus monkeys were trained under multiple fixed-ratio 30-response
schedules of food and i.v. cocaine delivery. Phentermine was always
given as a slow, i.v. infusion. Acute treatment with phentermine
(0.3-10 mg/kg) decreased cocaine-maintained responding at doses that
did not decrease, or decreased less, food-maintained responding for
each of three unit doses of cocaine (10-100 µg/kg/injection). Subacute treatment with phentermine (3 or 5.6 mg/kg, daily) also decreased cocaine-maintained responding more than food-maintained responding. After subacute treatment was terminated, rates of cocaine-maintained responding generally recovered to levels comparable to those seen during untreated control sessions. Phentermine (0.3-3 mg/kg) did not generally increase responding associated with a very low
(1 µg/kg/injection) unit dose of cocaine, suggesting that the
decrease in cocaine-maintained responding at higher unit doses was not
the result of a leftward shift in the cocaine unit dose-effect
function. Phentermine (0.1-3 mg/kg) decreased responding maintained by
1-[2-[bis(4-fluorophenyl) methoxy]ethyl]-4-[3-phenylpropyl] piperazine (GBR 12909) (30 µg/kg/injection) at doses similar to those
that decreased food-maintained responding. These results show that
phentermine is effective in decreasing cocaine self-administration and
suggest that it may be an effective medication for cocaine abuse.
This article has been cited by other articles:
![]() |
R. B. Rothman, B. E. Blough, W. L. Woolverton, K. G. Anderson, S. S. Negus, N. K. Mello, B. L. Roth, and M. H. Baumann Development of a Rationally Designed, Low Abuse Potential, Biogenic Amine Releaser That Suppresses Cocaine Self-Administration J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1361 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Carelli, S. G. Ijames, and A. J. Crumling Evidence That Separate Neural Circuits in the Nucleus Accumbens Encode Cocaine Versus "Natural" (Water and Food) Reward J. Neurosci., June 1, 2000; 20(11): 4255 - 4266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Negus, M. R. Brandt, and N. K. Mello Effects of the Long-Acting Monoamine Reuptake Inhibitor Indatraline on Cocaine Self-Administration in Rhesus Monkeys J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 60 - 69. [Abstract] [Full Text] |
||||